Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Diagnosis and Management of Vulvar Disorders
Description
The presentation on vulvar disorders by Kelly Tyler, a former OBGYN, emphasizes the importance of recognizing normal anatomy verses pathology in vulvar conditions. Tyler discusses common variations in vulvar anatomy, including hyperpigmentation and normal conditions like vestibular papillomatosis, and highlights the distinctions in how dermatological conditions manifest in the genital area compared to other body parts. Key topics include the diagnosis and management of vulvar dermatitis, particularly irritant and allergic contact dermatitis, along with underlying skin conditions such as psoriasis, lichen sclerosus, and lichen planus. Treatment protocols are detailed, emphasizing the use of topical steroids, the importance of patch testing for allergies, and the need for careful monitoring of patients to avoid misuse of medications. The presentation outlines specific biopsy techniques and the various chronic conditions that can arise from repetitive scratching. Tyler underscores the need for education on the appropriate use of medications and stress the importance of follow-up for effective management, particularly in preventing complications like squamous cell carcinoma in patients with untreated lichen sclerosus or lichen planus.
View moreConclusions
- Understanding normal variations in vulvar anatomy is crucial for accurate diagnosis.
- Differentiating between various vulvar disorders based on appearance and symptoms is key to effective treatment.
- Most common vulvar disorders include lichen sclerosis, lichen planus, and contact dermatitis, which require specific management approaches.
- Chronic vulvovaginal pruritus often results from either irritant or allergic contact dermatitis, indicating the need for patch testing in persistent cases.
- Inappropriate use of topical medications can exacerbate vulvar skin conditions, highlighting the importance of patient education and monitoring.
- Treatments such as topical corticosteroids are effective for managing lichen sclerosis and lichen planus, but require careful dosing and follow-up.
- SGLT2 inhibitors can lead to recurrent vulvar candidiasis, necessitating an evaluation of medication use in patients with vulvar itching.
- There is a significant risk of squamous cell carcinoma in patients with untreated lichen sclerosis, emphasizing the importance of regular monitoring and maintenance therapy.
- Farage MA, Miller KW. Determining the Cause of Vulvovaginal Symptoms. Obstet Gynecol Surv. 63 (2008) 445-464.
- L. Morrison, C. LeClair. Red Rashes of the Vulva. Obstet Gynecol Clin N Am 44 (2017) 353-370.
- Crone AM et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venerol: 14 (2000) 181-186.
- Brenan JA et al. Evaluation of patch testing in patients with chronic vulvar symptoms. Australas J Dermatol: 37 (1996) 40-43.
- Utas S et al. Patient with vulval pruritus: patch test results. Contact Dermatitis: 58 (2008) 296-298.
- Haverhoek et al. Prospective study of patch testing in patients with vulval pruritus. Australas J Dermatol: 49 (2008) 80-85.
- Forman JL, Mercurio MG. Vulvar Pruritus in Postmenopausal Diabetic Women With Candidiasis Secondary to Sodium-Glucose Cotransporter Receptor-2 Inhibitors. J Low Genit Tract Dis. 2023 Jan 1;27(1):68-70. doi: 10.1097/LGT.0000000000000704. Epub 2022 Sep 21.
- Mounsey SJ, Teo YX, Calonje JE, Lewis FM. Gliflozin (SGLT2 inhibitor) induced vulvitis. Int J Dermatol. 2023 Jan;62(1):62-65. doi: 10.1111/ijd.16449. Epub 2022 Oct 17.
- Akpala CO, Tekin B, Torgerson RR, Wetter DA, Nguyen GH. Treatment of lichen sclerosus with hydroxychloroquine: a Mayo Clinic experience. Int J Dermatol. 2024 Oct;63(10):e240-e243. doi: 10.1111/ijd.17394. Epub 2024 Jul 19.
- EA Dell, RYN Miest, CM Lohse, RR Torgerson. Vulvar Neoplasms in 275 Women With Genital Lichen Sclerosus and Impact of Treatment: A Retrospective Chart Review. J Eur Acad Dermatol Venereol. 2018 Mar 10;[EPub Ahead of Print].
- Chin S, Scurry J, Lee G, Fischer G. Association of Topical Corticosteroids with Reduced Vulvar SCC Recurrence in Patients with Vulvar Lichen Sclerosus. JAMA Dermatol. 2020 May 6. doi: 10.1001/jamadermatol.2020.1074. [Epub ahead of print].
- A Borghi, L D'Abundo, C Bassi, L Lupini, V Tagliatti, P Zedde, G Lanza, R Gafà, M Negrini, M Corazza. A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma. Br J Dermatol 2023 Apr 20;188(5):680-681.